Mustang Bio, Inc. (MBIO)
Nasdaq: MBIO · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2016
Who runs Mustang Bio, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Litchman Manuel Md
President, CEO and Interim CFO. First filing Jun 2017, latest Apr 27, 2026, 9 filings in all.
Officers reporting now
1
of 4 people with a filing in the last fifteen months
Directors reporting now
3
12 people on the record since 2016
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Litchman Manuel Md | President, CEO and Interim CFO | Jun 2017 | Apr 27, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chill Adam J. | director | Jun 2017 | Dec 30, 2025 | 1 · $0.00 |
| Herskowitz Neil | director | Jun 2017 | Dec 30, 2025 | 1 · $0.00 |
| Jin David | director | Oct 2024 | Dec 30, 2025 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Fortress Biotech, Inc. | 10% owner | Sep 2016 | Jan 5, 2026 | none |
Earlier names on the record8, newest filing first
Murphy James B · officer · last filing Feb 2024Carney Peter · officer · last filing Dec 2023Weiss Michael S · officer · last filing Jul 2023Rosenwald Lindsay A Md · director · last filing Jul 2023Zelefsky Michael J · director · last filing Jul 2023Lurier Eliot M · officer · last filing Jun 2022Achenbach Brian · officer · last filing Dec 2021Horin David J · officer · last filing Jun 2017
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.